[1] 中华人民共和国卫生部.临床输血技术规范[S].2000.
[2] CHEN C X,TAN J Z,WANG L X,et al.Unexpected red blood cell antibody distributions in Chinese people by a systematic literature review[J].Transfusion,2016,56(4):975-979.
[3] 李志强编著.简明临床输血理论与实践[M].上海:世界图书出版公司,2010.
[4] LUBAN N L C,MCBRIDE E,FORD J C,et al.Transfusion medicine problems and solutions for the pediatric hematologist/oncologist[J].Pediatr Blood Cancer,2012,58(7):1106-1111.
[5] Association for the Advancement of Blood & Biotherapies.血站和输血机构标准[M].徐蓓,聂晓绚,邱颖婕,主译.林俊杰,王迅,主审.第33版.上海:上海科学技术出版社,2023,43-44.
[6] NEW H V,BERRYMAN J,BOLTON-MAGGS P H B,et al.Guidelines on transfusion for fetuses,neonates and older children[J].Br J Haematol,2016,175(5):784-828.
[7] 国家卫生健康委员会.输血相容性检测标准[S].2022.
[8] GUYATT G H,OXMAN A D,VIST G E,et al.GRADE:an emerging consensus on rating quality of evidence and strength of recommendations[J].BMJ,2008,336(7650):924-926.
[9] BROZEK J L,AKL E A,ALONSO-COELLO P,et al.Grading quality of evidence and strength of recommendations in clinical practice guidelines.Part 1 of 3.An overview of the GRADE approach and grading quality of evidence about interventions[J].Allergy,2009,64(5):669-677.
[10] CROWE E P,GOEL R,AL-MOZAIN N,et al.Neonatal blood banking practices[J].Clin Perinatol,2023,50(4):821-837.
[11] 汪德清主编.输血技术操作规范(输血科部分)[M].北京:人民卫生出版社,2016.
[12] 李志强,吕先萍,刘铁梅,等.1周岁内婴幼儿月龄与ABO血型抗体凝集强度消长的多中心前瞻性研究[J].临床输血与检验,2021,23(4):450-454.
[13] 杨志诚. 微柱凝胶法在新生儿ABO血型鉴定中的应用[J].检验医学与临床,2008,5(24):1500-1501.
[14] KAPLAN A,GABERT K A,YAZER M H.Unexpectedly weak anti-B in 2 group O pediatric patients on parenteral nutrition and disease specific supplemental enteral feeds[J].Lab Med,2020,51(3):296-300.
[15] 尹明伟,陈学军,徐军,等.血型血清学结合PCR-SSP基因分型法在新生儿ABO血型鉴定中的应用[J].中国输血杂志,2020,33(10):1012-1016.
[16] HOWE J G,STACK G.Relationship of epitope glycosylation and other properties of blood group proteins to the immunogenicity of blood group antigens[J].Transfusion,2018,58(7):1739-1751.
[17] WESTHOFF C M.Blood group genotyping[J].Blood,2019,133(17):1814-1820.
[18] 邵明,杨乾坤,朱伟涛,等.6月龄内婴幼儿ABO/RhD的血型结果及两种检测方法的对比分析[J].中国实验血液学杂志,2021,29(5):1589-1594.
[19] 马曙轩,田军,薛晖.2种微柱凝胶卡鉴定3岁以下婴幼儿ABO及血型对比研究[J].临床输血与检验,2012,14(1):29-31.
[20] SANDLER S G,QUEENAN J T.A guide to terminology for Rh immunoprophylaxis[J].Obstet Gynecol,2017,130(3):633-635.
[21] BARRITEAU C M,LINDHOLM P F,HARTMAN K,et al.RHD genotyping to resolve weak and discrepant RhD patient phenotypes[J].Transfusion,2022,62(11):2194-2199.
[22] 陈伟,李菲,马筱洁,等.9例新生儿高效价RhD抗体导致胎儿新生儿溶血病且形成RhD抗原遮蔽现象的回顾性分析与对策[J].临床血液学杂志,2021,34(6):423-427.
[23] WANG H J,CHEN J,JIANG Y M.A case of a newborn with blocked RhD antigen and HDFN[J].Lab Med,2017,48(4):381-383.
[24] DAS S,SHASTRY S,BALIGA P B.Severe haemolytic disease of a newborn with variant D mimicking blocked-D phenomenon[J].BMJ Case Rep,2019,12(12):e231891.
[25] CROWE E P,GOEL R,ANDREWS J,et al.Survey of newborn direct antiglobulin testing practice in United States and Canadian transfusion services[J].Transfusion,2021,61(4):1080-1092.
[26] ZONNEVELD R,LAMERS M,SCHONEWILLE H,et al.Prevalence of positive direct antiglobulin test and clinical outcomes in Surinamese newborns from D-negative women[J].Transfusion,2017,57(10):2496-2501.
[27] SHIN K H,LEE H J,SONG D,et al.Characteristics of bilirubin according to the results of the direct antiglobulin test and its impact in hemolytic disease of the newborn[J].Lab Med,2019,50(2):138-144.
[28] DAS S,SHASTRY S,CHAKRAVARTHY P K,et al.Clinical Implication of Immunohaematological Tests in ABO haemolytic disease of newborn:Revisiting an old disease[J].Transfus Med,2021,31(1):30-35.
[29] IRVING C,CRENNAN M,VANNIASINKAM T.Can serological methods help distinguish between prophylactic and alloimmune anti-D?[J].Transfus Med,2017,27(Suppl 5):362-368.
[30] BRANCH D R,SCOFIELD T L,MOULDS J J,et al.Unexpected suppression of anti-Fya and prevention of hemolytic disease of the fetus and newborn after administration of Rh immune globulin[J].Transfusion,2011,51(4):816-819.
[31] RAGUZ M J,PRCE Z,BJELANOVIC V,et al.20 years of follow-up alloimmunization and hemolytic disease in newborn:has anything changed in the field over the years?[J].Klin Padiatr,2020,232(6):314-320.
[32] YU Y,MA C,SUN X,et al.Frequencies of red blood cell major blood group antigens and phenotypes in the Chinese Han population from Mainland China[J].Int J Immunogenet,2016,43(4):226-235.
[33] TAMAI Y,OHTO H,YASUDA H,et al.Allo-anti-M:detection peaks around 2 years of age,but may be attenuated by red blood cell transfusion[J].Transfusion,2021,61(9):2718-2726.
[34] JUDD W J.When should tests for unexpected antibodies be done during pregnancy?[J].Transfusion,2011,51(7):1366-1368.
[35] MAROTO A,MARTINEZ-DIAGO C,TIO G,et al.Autoimmune hemolytic anemia in pregnancy:a challenge for maternal and fetal follow-up[J].J Matern Fetal Neonatal Med,2022,35(5):996-998.
[36] HUNDRIC-HASPL Z,BALEN-MARUNIC S,TOMASIC-SUSANJ E,et al.Anti-Diego a red blood cell alloantibody as a possible cause of anemia in a 3-week-old infant[J].Arch Med Res,2003,34(2):149-151.
[37] CHEN J H,LIU F.A case of mild HDFN caused by anti-C,anti-D,and anti-G:diagnostic strategy and clinical significance of distinguishing anti-G from anti-D and anti-C[J].Transfus Apher Sci,2020,59(1):102602.
[38] 党创伟,李自锋,刘钊锋,等.新生儿ABO同型血交叉配血不合原因及安全输血分析[J].内科,2022,17(1):102-104.
[39] BERENTSEN S,RANDEN U,OKSMAN M,et al.Bendamustine plus rituximab for chronic cold agglutinin disease:results of a Nordic prospective multicenter trial[J].Blood,2017,130(4):537-541.
[40] WEBB J,DELANEY M.Red blood cell alloimmunization in the pregnant patient[J].Transfus Med Rev,2018,32(4):213-219.
[41] 金晓红,屈柯暄,陈蕊,等.静脉丙种球蛋白致婴幼儿产生IgG类抗体及交叉配血不合6例[J].中国输血杂志,2021,34(7):776-778.
[42] LOH C L Y,LAM J C M.Importance of antenatal blood group typing and antibody screening in non-ABO/Rh haemolytic disease of the newborn[J].Ann Acad Med Singap,2021,50(1):84-85.
[43] BU X M,SUN P,WAN Y Z.ABO haemolytic disease of the fetus and newborn in a blood group AB neonate due to maternal immunoglobulin G anti-A and anti-B antibodies[J].Br J Haematol,2021,192(3):416.
[44] 李志强主编.输血医学精编[M].上海:上海交通大学出版社,2023. |
